气相色谱质谱法测定功能性饮料中的肌醇

研究建立了功能性饮料中肌醇的气相色谱/质谱(GC/MS)测定方法.样品经浓缩、硅烷化后以正己烷提取,用气相色谱/质谱仪外标法测定其含量.此方法回收率范围为90.0%～105%;变异系数为2.0%～5.0%.方法适合于功能性饮料中肌醇的分析测定.     

气相色谱-质谱法测定眼用全氟丙烷气体中甲醇、甲醛

建立气相色谱–质谱(GC–MS)联用法与气相色谱(GC)法测定眼用全氟丙烷气体中甲醇、甲醛杂质的方法。甲醇采用GC–MS法定性、GC法定量分析,在51.1～511μL/L浓度范围内线性良好(r~2=0.998 5),检出限为4μL/L,测量结果的相对标准偏差为2.73%(n=6),加标回收率为91%～94%;甲醛采用GC–MS定性、定量分析,质谱选择离子(SIM)模式以m/z 29作为甲醛的定量离子,在21.36～106.8μL/L浓度范围内线性良好(r~2=0.999 1),检出限为5μL/L,测量结果的相对标准偏差为3.19%(n=6),加标回收率为89%～94%。该方法灵敏度高,重复性好,简便可行,可用于眼用全氟丙烷气体的质量控制。     

气相色谱/质谱法测定鱼塘中的痕量硫丹

利用气相色谱/质谱(GC/MS),测定了鱼塘中痕量的硫丹,同时实现了硫丹的定性、定量.样品提取简便、高效,无需净化.用GC/MS的选择离子记录(SIR)方式测定低浓度硫丹的含量.硫丹在0.2～1000.0μg/mL范围内呈线性,该方法的检出限为0.086μg/mL,标准添加1.0、50μg/mL硫丹的回收率为87%、92%,测定的相对标准偏差为6.2%、13.1%.本方法能够满足痕量分析的实际要求.     

气质联用仪法测定奶粉中多环芳烃

研究了奶粉中多环芳烃的气相色谱/质谱(GC/MS)测定方法. 样品经甲醇-KOH皂化后用甲苯提取, 提取液经微孔滤膜过滤后用气相色谱质谱仪测定其含量, 外标法定量. 结果16种PAHs的回收率范围为92.0%～106%;RSD为2.2%～4.7%. 方法能同时分离16种PAHs, 适合于奶粉中多环芳烃的分析测定.     

气相色谱/氢火焰检测器检测HL-60细胞DNA中氧化损伤产物8-羟基鸟嘌呤的研究

用0．4mmol／LH2O2处理HL－60细胞株24h,采用气相色谱／氢火焰检测器（GC／FID）检测DNA氧化损伤产物8-羟基鸟嘌呤,并用气相色谱质谱仪选择性离子检测（CGC／MS－SIM）对其进一步鉴定。所用方法的平均回收率为81．7％,RSD小于5％。     

气相色谱-质谱法测定蔬菜与水果中11种三唑类农药残留

建立了蔬菜和水果中11种三唑类农药残留的气相色谱-质谱(GC - MS)测定方法.样品用乙腈均质提取,经石墨化炭黑/氨基复合柱净化,乙腈-甲苯(3:1)洗脱.洗脱液经浓缩、溶剂交换后定容,采用气相色谱-质谱的选择离子监测方式( GC - MSD/SIM)进行测定,内标法定量.方法的线性范围为0.05～5 ng,相关系数...     

溶剂浮选-气相色谱/质谱法测定蔬菜中氨基甲酸酯类农药残留

建立了一种有效分离富集并榆测蔬菜中氨基甲酸酯类农药残留的方法,即采用溶剂浮选法(SS)对蔬菜中的氨基甲酸酯类农药残留进行分离富集.然后用气相色谱,质谱(GC/MS)进行检测.考察了浮选溶剂、试液pH、通气速度及浮选时间等因索对浮选效果的影响,得剑了优化浮选条件 对此条件下的浮选产物进行气相色谱/质谱检测,回收率为81.6%～97.8%,RSD为1.39%～2.65%,定量限(LOQ)为0.39-6.17 pg/kg.     

环境水样中二甲胺和二乙胺的检测方法比较

采用气相色谱法(GC)和顶空-气相色谱/质谱法(HS-GC/MS) 测定环境水样中的二甲胺和二乙胺.优化的实验条件如下:载气为高纯氮气,流速为1 mL/min,柱温:35℃,保持15 min,以 5℃/min速度升至 80℃(GC);顶空温度80 ℃,平衡时间30 min,柱温50 ℃,离子源温度230 ℃ (HS-GC/MS).将10 mL水样移入20 mL顶空瓶中,将顶空瓶用铝盖密封.放入自动顶空进样系统中加热进行分析.在上述条件下,二甲胺(1.80～35.9 mg/L)和二乙胺(1.42～28.4 mg/L)的线性良好.GC和HS-GC/MS测定二甲胺的检出限分别为8.6和10.1 mg/L,测定二乙胺的检出限分别为0.09和0.12 mg/L; 水样平均加标回收率分别为52.6%～56 2%和86.8%～109.6%;相对标准偏差分别为2.0%,5.8%,5.5%,2.0%.结果表明,在分析挥发性的胺类物质时HS-GC/MS比GC具有较强优势.它可省略蒸馏浓缩预处理步骤,直接进样,是一种测定环境水中二甲胺和二乙胺的有效分析方法.     

茚虫威残留的气相色谱-质谱联用法测定

研究了用固相萃取(SPE)-选择离子(SIM) -气相色谱(GC) -质谱(MS)联用法测定蔬菜、水果中茚虫威残留的分析方法.样品采用乙腈超声波均质提取,固相萃取柱净化,丙酮定容.添加量为0.05 μg ～ 1.00μg时,回收率为86.5％ ～ 107.2％,相对标准偏差(RSD)＜5.0％,定量检出限为:0.001...     

甲氧滴涕原药成分的气相色谱和气相色谱-质谱分析

本文用气相色谱（GC），气相色谱-质谱联用（GC－MS）测定了甲氧滴涕（DMDT）原药中有效成分的含量及11种成分的结构。GC法内标定量结果表明，产品甲氧滴涕原药中有效成份达90％以上。     

Determination of Meperidine in Human Plasma and Urine by Gas-Liquid Chromatography

Abstract

A highly sensitive method for the determination of meperidine and normeperidine in biological fluids is presented. Concentrations as low as 5 ng meperidine and 25 ng normeperidine per ml of sample can be determined. The recovery of meperidine from control plasma and urine was 91.3 to 102.5% and the recovery of normeperidine was 64.7 to 82.8%. The method has been successfully used for the determination of meperidine in human plasma and urine and of normeperidine in human urine.     

Determination of free and conjugated cis-3,3,5-trimethylcyclohexanol in plasma and urine

A gas chromatographic procedure was developed to determine free and conjugated cis-3,3,5-trimethylcylcohexanol in plasma and urine. The sample is extracted with dichloromethane when free cis-3,3,5-trimethylcyclohexanol is determined, or with hexane after enzymatic hydrolysis, when conjugated cis-3,3,5-trimethylcyclohexanol is determined. An aliquot of the organic extract is injected into a stainless-steel column (packed with Carbowax 20M, 15% on Chromosorb W AW 100-120 mesh) and detected with a flame ionization detector. Extraction recovery from plasma and urine was almost 100% and the limit of quantification was fixed at 100 ng/ml plasma or urine. The procedure was evaluated in a pharmacokinetic study of cyclandelate and its metabolite cis-3,3,5-trimethylcyclohexanol.     

气相法分析血浆中的全氟辛酸

 采用气相 电子捕获法测定了人血浆中全氟辛酸的含量。将血浆中的全氟辛酸酯化后进行分析 ,以全氟癸酸为内标。柱为HP 1熔融石英毛细管柱 (30m× 0 2 5mmi.d .× 0 2 5 μm)。方法的线性范围为 2 0 0 0μg/L～ 4 0 0× 10 3 μg/L ,线性相关系数r =0 994 6。平均回收率为 99 2 % ,相对标准偏差 (RSD)为 0 95 % ,血浆中全氟辛酸的检出限为 6 0 μg/L。方法准确、可靠 ,分析结果令人满意。     

气相色谱-氮磷检测法检测尿中劳拉西泮

 报道了尿中劳拉西泮的气相色谱 氮磷检测器的检测方法。检测时以 2 羟乙基氟西泮为内标 ,用 β 葡萄糖醛酸苷酶水解后于碱性条件下用乙醚萃取 ,将萃取液浓缩后进行检测。劳拉西泮的萃取率 (mean±SD)为 ( 83 4±3 1) % ,检出限为 5 μg/L。萃取物用N ,O 双 (三甲硅烷基 )三氟乙酰胺 (BSTFA)衍生化后进行三甲基硅烷 (TMS)衍生物检测。     

人体血中美百乐镇（PRAVASTATIN）浓度的气相色谱／质谱测定法

报道了采用乙酸乙酯萃取纯化样品,经重氮甲烷酯化、ＢＳＴＦＡ硅烷化后,用气相色谱－质谱法的选择离子检测（ＳＩＭ）定量模型,对ｐｒａｖａｓｔａｔｉｎ的血药浓度进行测定的方法。方法的最低检出限为０．０１５ｎｇ,在１．０～６０ｎｇ／ｍＬ的浓度范围内,标准曲线呈良好的线性关系,ｒ＞０．９９,ＣＶ＜７．７％。     

稳定同位素稀释离子色谱-三重四极杆质谱法测定血浆和尿液中的氟乙酸

建立了离子色谱-三重四极杆质谱测定血浆和尿液样品中氟乙酸（MFA）的方法。血浆样品经高氯酸超声提取,尿液样品经高氯酸酸化,血浆和尿液提取液在pH 0.5~1.0条件下用叔丁基甲醚（MTBE）萃取,萃取液经氮吹浓缩后溶于0.1%（v/v）氨水溶液。以Ionpac AS 19型阴离子色谱柱为分析柱,在线自动产生的氢氧化钾作为淋洗液进行梯度分离,柱流出液经阴离子抑制器抑制后进入质谱系统。采用电喷雾电离源,在负离子、多离子监测（MRM）模式下检测,¹³C₂-氟乙酸稳定同位素内标法定量。血浆和尿液样品中氟乙酸的平均加标回收率为96.2%~120%,相对标准偏差为1.1%~13.1%（n=6）,方法的检出限（S/N=3）分别为0.03 μg/L和0.1 μg/L。该法简单、灵敏、准确,可用于生物样品中氟乙酸的检测。     

High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine.

A sensitive reversed-phase high-performance liquid chromatographic (HPLC) technique with ultraviolet detection has been developed to determine the concentration of BRB-I-28 (I), a novel antiarrhythmic agent, in dog plasma and urine. The mobile phase was acetonitrile-methanol-37.5 mM phosphate buffer, pH 6.8-triethylamine (50:50:75:0.1, v/v). The compound was extracted from dog plasma and urine with chloroform after alkalinization with sodium hydroxide. The extraction recovery was 83% from plasma and 84% from urine. Good linearity (r > 0.996) was observed throughout the ranges 0.1-12.0 micrograms/ml (plasma) and 0.1-8.0 micrograms/ml (urine). Intra- and inter-assay variabilities were less than 4%. The lower limit of quantitation was 0.08 microgram/ml in either plasma or urine. HPLC analysis of plasma and urine samples from a dog treated with I has demonstrated that the method was accurate and reproducible.     

气相色谱-微池电子捕获器检测尿液中的三唑仑

建立了气相色谱-微池电子捕获检测器(GC-μECD)检测尿液中三唑仑的方法。筛选了pH值、提取溶剂、涡旋时间,优化了液-液萃 取条件。在0.2～50 ng/mL范围内,线性关系良好,相关系数为0.9995;方法的检出限为0.1 ng/mL,日内和日间测定的相对标准偏差分 别为4.17%和5.31%,平均回收率为93.9%。该方法操作简便、灵敏度高、线性范围广、回收率高,完全能够满足日常检测工作的需要。     

Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

A highly sensitive and selective high-performance liquid chromatographic method, involving sample pre-treatment, column switching and fluorimetric detection, is described for the determination of dihydroergotamine in plasma and urine samples. The pre-chromatographic sample treatment consists of extraction by means of an Extrelut column for plasma samples, and pre-separation with enrichment steps on a Sep-Pak column for urine samples. The samples are then injected onto a pre-separation column (Aquapore), and the fraction containing dihydroergotamine are automatically diverted onto an analytical column (ODS reversed phase). An acetonitrile-ammonium carbamate gradient is used as the mobile phase. High recovery of dihydroergotamine from both plasma (87%) and urine (100%) and a detection limit as low as 100 pg/ml were achieved, with a linear response up to 5 ng/ml. The assay demonstrated a high degree of selectivity with regard to the extensive metabolism of dihydroergotamine especially to the main metabolite 8'-hydroxydihydroergotamine. The assay was successfully applied for more than one year to the determination of plasma and urine concentrations of dihydroergotamine after parenteral administration.     

Simultaneous determination of morphine‐6‐d‐glucuronide,morphine‐3‐d‐glucuronide and morphine in human plasma and urine by ultra‐performance liquid chromatography–tandem mass spectrometry: Application to M6G injection pharmacokinetic study

A robust ultra‐performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method for the determination of morphine‐6‐d ‐glucuronide (M6G), morphine‐3‐d ‐glucuronide (M3G) and morphine (MOR) in human plasma and urine has been developed and validated. The analytes of interest were extracted from plasma by protein precipitation. The urine sample was prepared by dilution. Both plasma and urine samples were chromatographed on an Acquity UPLC HSS T₃ column using gradient elution. Detection was performed on a Xevo TQ‐S tandem mass spectrometer in multiple reaction monitoring mode using positive electrospray ionization. Matrix interferences were not observed at the retention time of the analytes and internal standard, naloxone‐D5. The lower limits of quantitation of plasma and urine were 2/0.5/0.5 and 20/4/2 ng/mL for M6G/M3G/MOR, respectively. Calibration curves were linear over the concentration ranges of 2–2000/0.5–500/0.5–500 and 20–20,000/4–4000/2–2000 ng/mL for M6G/M3G/MOR in plasma and urine samples, respectively. The precision was <7.14% and the accuracy was within 85–115%. Furthermore, stability of the analytes at various conditions, dilution integrity, extraction recovery and matrix effect were assessed. Finally, this quantitative method was successfully applied to the pharmacokinetic study of M6G injection in Chinese noncancer pain patients.